ArticleBreast cancer research and treatment2012

Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.

Babette Siebold Saltzman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.